切换至 "中华医学电子期刊资源库"

中华口腔医学研究杂志(电子版) ›› 2016, Vol. 10 ›› Issue (06) : 377 -382. doi: 10.3877/cma.j.issn.1674-1366.2016.06.003

所属专题: 文献

基础研究

Bmi1在舌鳞状细胞癌组织中的表达及其与临床病理特征和预后的关系
何倩婷1, 汤磊乐2, 王伟1, 孙菁菁1, 王安训1,()   
  1. 1. 510080 广州,中山大学附属第一医院口腔科
    2. 510630 广州,中山大学附属第三医院心内科
  • 收稿日期:2016-08-14 出版日期:2016-12-01
  • 通信作者: 王安训
  • 基金资助:
    国家自然科学基金(81472523); 广东省自然科学基金(2015A030313017)

The expression of Bmi1 in tongue squamous cell carcinoma and its relationship with the clinicopathological characteristics and prognosis

Qianting He1, Leile Tang2, Wei Wang1, Jingjing Sun1, Anxun Wang1,()   

  1. 1. Department of Stomatology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
    2. Department of Cardiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China
  • Received:2016-08-14 Published:2016-12-01
  • Corresponding author: Anxun Wang
  • About author:
    Corresponding author: Wang Anxun, Email:
引用本文:

何倩婷, 汤磊乐, 王伟, 孙菁菁, 王安训. Bmi1在舌鳞状细胞癌组织中的表达及其与临床病理特征和预后的关系[J/OL]. 中华口腔医学研究杂志(电子版), 2016, 10(06): 377-382.

Qianting He, Leile Tang, Wei Wang, Jingjing Sun, Anxun Wang. The expression of Bmi1 in tongue squamous cell carcinoma and its relationship with the clinicopathological characteristics and prognosis[J/OL]. Chinese Journal of Stomatological Research(Electronic Edition), 2016, 10(06): 377-382.

目的

探讨Bmi1在舌鳞状细胞癌(TSCC)发生、发展过程中的作用。

方法

采用免疫组化法对收集的77例TSCC组织、22例舌癌前病变(白斑)以及12例正常舌组织中Bmi1表达水平进行检测。应用SPSS 17.0对数据进行处理分析。组间比较采用t检验和单因素方差分析。Bmi1的表达与TSCC患者临床病理因素间的相关性分析采用Pearson和Spearman相关检验。TSCC患者的Bmi1生存曲线分析采用Kaplan-Meier法,曲线间比较采用Log-rank检验。以P<0.05为差异有统计学意义。

结果

白斑和TSCC组织中Bmi1的表达水平显著高于正常舌组织(白斑与正常舌组织对比的P= 0.014;TSCC与正常舌组织对比的P= 0.036);中、重度白斑中Bmi1的表达水平明显高于轻度白斑(P= 0.014)。颈淋巴结转移阳性的TSCC患者标本的Bmi1表达水平显著高于颈淋巴结转移阴性患者(P= 0.006);同时,晚期患者的组织标本中Bmi1的表达水平亦明显高于早期患者(P= 0.004)。TSCC组织标本中的Bmi1表达水平与患者的年龄、性别、肿瘤大小无明显相关性,但与颈淋巴结转移阳性和临床分期呈显著正相关,差异具有统计学意义(P<0.05)。同时Bmi1与SOD2和Ki67的表达水平呈正相关(P<0.05)。Bmi1高表达组的5年生存率低于Bmi1低表达组,二者之间差异具有统计学意义(P<0.001)。

结论

TSCC和白斑患者的组织标本中Bmi1的表达水平增加,表明在舌恶性肿瘤发生的早期阶段已存在Bmi1的表达,并对TSCC的发生、发展和预后产生重要影响。

Objective

To investigate the role of Bmi1 in the initiation and development of tongue squamous cell carcinoma (TSCC) .

Methods

The immunohistochemistry analysis was performed to analysis the expression level of Bmi1 in 77 TSCC cases, 22 leukoplakia cases and 12 normal tongue biopsies. The data were analyzed using SPSS 17.0. One-Way ANOVA and Student′s t-test were used to compare the differences between groups. Pearson and Spearman correlation coefficients were used to assess correlations among the Bmi1 gene expression and clinical and histopathological parameters of TSCC patients. Bmi1 Survival curves of TSCC patients were plotted using the Kaplan-Meier method and compared using the log-rank test. For all statistical analyses, P<0.05 was considered statistically significant.

Results

Bmi1 expression was significantly higher in LP and TSCC than in normal tongue tissue (P= 0.014; P= 0.036) . For LP cases, Bmi1 expression was also significantly higher in moderate and severe ones than in light ones (P= 0.014) . For TSCC cases, the expression level of Bmi1 was significantly higher in the patients with positive node metastasis status than those with negative status (P= 0.006) , and in late-stage (stages Ⅲ and Ⅳ) than in early-stage disease (stages Ⅰ and Ⅱ) (P= 0.004) . There was no significant correlation between the expression of Bmi1 and age, gender, or pT stage in the present study. However, strong positive correlations were observed between the expression of Bmi1 and pN and the clinical stages (P<0.05) . Significant positive correlation was also observed among Bmi1 expression, SOD2 expression and Ki67 expression (P<0.05) . There was a significantly higher 5-year survival rate in low Bmi1 expression group than in high Bmi1 expression group (P<0.001) .

Conclusions

Bmi1 expression was significantly higher in TSCC and LP tissues. Bmi1 expression began at the early stage of TSCC, and played an important role in the initiation and progression of TSCC.

表1 本研究舌鳞状细胞癌、白斑患者及正常舌组织的临床病理相关资料[例(%)]
图1 舌鳞状细胞癌中Bmi1表达水平等级判定标准图(DAB)
图2 Bmi1在正常组织、舌鳞状细胞癌及白斑中的表达(DAB)
图3 Bmi1在白斑、舌鳞状细胞癌组织中的表达水平对比图
表2 77例舌鳞状细胞癌患者Bmi1的表达与临床病理资料的相关性
图4 舌鳞状细胞癌患者Bmi1表达的生存分析图
[1]
Haddad RI, Shin DM. Recent advances in head and neck cancer[J]. N Engl J Med,2008,359(11):1143-1154.
[2]
Liu W, Feng JQ, Shen XM,et al. Two stem cell markers,ATP-binding cassette,G2 subfamily(ABCG2)and BMI-1,predict the transformation of oral leukoplakia to cancer:a long-term follow-up study[J]. Cancer,2012,118(6):1693-1700.
[3]
Ma L, Wang H, Yao H,et al. Bmi1 expression in oral lichen planus and the risk of progression to oral squamous cell carcinoma[J]. Ann Diagn Pathol,2013,17(4):327-330.
[4]
Häyry V, Mäkinen LK, Atula T,et al. Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue[J]. Br J Cancer,2010,102(5):892-897.
[5]
Saudy NS, Fawzy IM, Azmy E,et al. BMI1 gene expression in myeloid leukemias and its impact on prognosis[J]. Blood Cells Mol Dis,2014,53(4):194-198.
[6]
Song LB, Li J, Liao WT,et al. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells[J]. J Clin Invest,2009,119(12):3626-3636.
[7]
Proctor E, Waghray M, Lee CJ,et al. Bmi1 enhances tumorigenicity and cancer stem cell function in pancreatic adenocarcinoma[J]. PLoS One,2013,8(2):e55820.
[8]
Lukacs RU, Memarzadeh S, Wu H,et al. Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation[J]. Cell Stem Cell,2010,7(6):682-693.
[9]
Du J, Li Y, Li J,et al. Polycomb group protein Bmi1 expression in colon cancers predicts the survival[J]. Med Oncol,2010,27(4):1273-1276.
[10]
Feng JQ, Xu ZY, Shi LJ,et al. Expression of cancer stem cell markers ALDH1 and Bmi1 in oral erythroplakia and the risk of oral cancer[J]. J Oral Pathol Med,2013,42(2):148-153.
[11]
Chen H, Zhou L, Wan G,et al. BMI1 promotes the progression of laryngeal squamous cell carcinoma[J]. Oral Oncology,2011,47(6):472-481.
[12]
Kang MK, Kim RH, Kim SJ,et al. Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival[J]. Br J Cancer,2007,96(1):126-133.
[1] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[2] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[3] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[4] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[5] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[6] 陈樽, 王平, 金华, 周美玲, 李青青, 黄永刚. 肌肉减少症预测结直肠癌术后切口疝发生的应用研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 639-644.
[7] 关小玲, 周文营, 陈洪平. PTAAR在乙肝相关慢加急性肝衰竭患者短期预后中的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 841-845.
[8] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[9] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[10] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[11] 董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
[12] 刘郁, 段绍斌, 丁志翔, 史志涛. miR-34a-5p 在结肠癌患者的表达及其与临床特征及预后的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 485-490.
[13] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
[14] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[15] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
阅读次数
全文


摘要